Nicole L Buist

Nicole L Buist

Central US Merck & Co., Inc. - Kenilworth / United States
Others
AD Scientific Index ID: 5513385
-
person_outline Nicole L Buist's MOST POPULAR ARTICLES
1-) A series of novel, highly potent, and orally bioavailable next-generation tricyclic peptide PCSK9 inhibitorsTJ Tucker, MW Embrey, C Alleyne, RP Amin, A Bass, B Bhatt, E Bianchi, ...Journal of Medicinal Chemistry 64 (22), 16770-16800, 2021782021
2-) A proximal bisnitroxide initiator: studies in low-temperature nitroxide-mediated polymerizationsJ Ruehl, NL Hill, ED Walter, G Millhauser, R BraslauMacromolecules 41 (6), 1972-1982, 2008402008
3-) Synthesis and characterization of a novel bisnitroxide initiator for effecting “outside-in” polymerizationNL Hill, R BraslauMacromolecules 38 (22), 9066-9074, 2005382005
4-) Discovery of MK-8831, a novel spiro-proline macrocycle as a pan-genotypic HCV-NS3/4a protease inhibitorSF Neelamkavil, S Agrawal, T Bara, C Bennett, S Bhat, D Biswas, ...ACS Medicinal Chemistry Letters 7 (1), 111-116, 2016332016
5-) Discovery of Benzimidazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus MonkeysSB Hoyt, MK Park, C London, Y Xiong, J Tata, DJ Bennett, A Cooke, J Cai, ...ACS medicinal chemistry letters 6 (5), 573-578, 2015272015